Cardiocomm Solutions (TSE:EKG) has released an update.
CardioComm Solutions has received Health Canada clearance for its GEMS™ Rhythm AI software, enhancing its ECG monitoring solutions with the automated detection of multiple cardiac arrhythmias and abnormalities. The technology is pivotal for the company’s roadmap, aiming to integrate it with various ECG monitoring products for flexible and comprehensive patient care. With this advancement, CardioComm strengthens its product lineup, which includes home ECG devices and multi-signal monitoring solutions.
For further insights into TSE:EKG stock, check out TipRanks’ Stock Analysis page.
